8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 13, 2016)

Filed September 13, 2016For Securities:ELV

Summary

Elevance Health, Inc. (then Anthem, Inc.) filed an 8-K on September 13, 2016, primarily to reaffirm its financial guidance for the full year 2016. The company stated that it expected net income to be greater than $9.34 per share, which included over $1.46 per share in net unfavorable items. Excluding these items, the adjusted net income was projected to exceed $10.80 per share. This guidance was consistent with figures reported in their second-quarter earnings release and did not account for any further adjustments beyond those already identified.

Key Highlights

  • 1Reaffirmed full-year 2016 net income guidance above $9.34 per share.
  • 2Projected net unfavorable items for full-year 2016 to be greater than $1.46 per share.
  • 3Expected adjusted net income for full-year 2016 to be greater than $10.80 per share.
  • 4Guidance is based on information available as of the second quarter of 2016 earnings release.
  • 5No new adjustments beyond those previously reported are included in the guidance.
  • 6The report includes standard forward-looking statement disclaimers regarding potential risks and uncertainties.

Frequently Asked Questions

The primary purpose of this 8-K filing is to reaffirm Elevance Health's (then Anthem, Inc.) financial guidance for the full fiscal year 2016 during meetings with securities analysts and investors.

The company reaffirmed its guidance for full-year 2016 net income to be greater than $9.34 per share, including net unfavorable items exceeding $1.46 per share. Excluding these items, adjusted net income was expected to be greater than $10.80 per share.

No, the guidance stated in this 8-K does not include any adjustments beyond those that were already reported in Elevance Health's second-quarter 2016 earnings release.

While this filing's primary focus is guidance reaffirmation, it includes a standard 'forward-looking statements' section detailing various risks and uncertainties. These include regulatory changes, healthcare cost trends, the pending acquisition of Cigna Corporation, litigation, cyber security risks, and general economic conditions, among others.